JACC: Basic to Translational Science (May 2021)

Can a Biohybrid Patch Salvage Ventricular Function at a Late Time Point in the Post-Infarction Remodeling Process?

  • Lindemberg M. Silveira-Filho, MD, PhD,
  • Garrett N. Coyan, MD, MS,
  • Arianna Adamo, MS,
  • Samuel K. Luketich, MS,
  • Giorgio Menallo, BSc, MSc,
  • Antonio D’Amore, PhD,
  • William R. Wagner, PhD

Journal volume & issue
Vol. 6, no. 5
pp. 447 – 463

Abstract

Read online

Summary: A biohybrid patch without cellular components was implanted over large infarcted areas in severely dilated hearts. Nonpatched animals were assigned to control or losartan therapy. Patch-implanted animals responded with better morphological and functional echocardiographic endpoints, which were more evident in a subgroup of animals with very low pre-treatment ejection fraction (<35%). Patched animals also had smaller infarcts than both nonpatched groups. This simple approach could hold promise for clinical translation and be applied using minimally invasive procedures over the epicardium in a large set of patients to induce better ventricular remodeling, especially among those who are especially frail.

Keywords